Metry, Andrew
29  results:
Search for persons X
?
2

Early Cost-Utility Analysis of Ataluren and Eteplirsen in t..:

Shehata, Zahraa ; Metry, Andrew ; Rabea, Hoda...
Value in Health Regional Issues.  38 (2023)  - p. 109-117 , 2023
 
?
7

Cost-effectiveness of therapeutics for COVID-19 patients: a..:

Metry, Andrew ; Pandor, Abdullah ; Ren, Shijie...
Metry , A , Pandor , A , Ren , S , Shippam , A , Clowes , M , Dark , P , McMullan , R & Stevenson , M 2023 , ' Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis ' , Health technology assessment (Winchester, England) , vol. 27 , no. 14 , pp. 1-92 . https://doi.org/10.3310/NAFW3527.  , 2023
 
?
 
?
12

Cost effectiveness of Ranibizumab vs Aflibercept vs Bevaciz..:

Pennington, Becky ; Alshreef, Abualbishr ; Flight, Laura...
Pennington , B , Alshreef , A , Flight , L , Metry , A , Poku , E , Hykin , P , Sivaprasad , S , Prevost , A T , Vasconcelos , J C , Murphy , C , Kelly , J , Yang , Y , Lotery , A , Williams , M & Brazier , J 2021 , ' Cost effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the treatment of macular oedema due to central retinal vein occlusion: the LEAVO study ' , PharmacoEconomics , vol. 39 , no. 8 , pp. 913–927 . https://doi.org/10.1007/s40273-021-01026-5.  , 2021
 
1-15